Overexpression of MAL2 Correlates with Immune Infiltration and Poor Prognosis in Breast Cancer.
Yue ZhongZhenjie ZhuangPeiJu MoQi ShangMandi LinJiaQian GongJiaRong HuangHaiYan MoMei HuangPublished in: Evidence-based complementary and alternative medicine : eCAM (2021)
Overexpression of MAL2 correlates with poor prognosis and lower immune infiltrating levels of eosinophils and plasmacytoid dendritic cells in breast cancer and may become a biomarker for breast cancer prognosis.